Eric Bradford - Concepedia

Author

Eric Bradford

Also Known As

Bradford, Eric, Bradford, Eric S., E Bradford, E S Bradford, E. Bradford, E.S. Bradford, Eric Bradford, Eric S Bradford, Eric S. Bradford, O’Neal, Wanda K

106

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Research Triangle Park Foundation GlaxoSmithKline (United States)GlaxoSmithKline (United Kingdom)University of Oxford Age UK

About

Eric Bradford is an author at Research Triangle Park Foundation specializing in asthma, medicine, and allergy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	773
2	Allergy	6	6	773
3	Allergy Medicine	5	5	699
4	Public Health	1	1	74
5	Epidemiology	1	1	74

Eric Bradford

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial Geoffrey Chupp, Eric Bradford, Frank C. Albers, The Lancet Respiratory Medicine AsthmaAllergyHealth-related QualityAllergy MedicineImmunology	2017	571
Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease Ian Pavord, Pascal Chanez, Gerard J. Criner, New England Journal of Medicine	2017	563
Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma Sumita Khatri, Wendy C. Moore, Peter G. Gibson, Journal of Allergy and Clinical Immunology	2018	289
Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trial Florence Roufosse, Jean‐Emmanuel Kahn, Marc E. Rothenberg, Journal of Allergy and Clinical Immunology	2020	176
Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: The COSMEX Study Sandhya Khurana, Guy Brusselle, Elisabeth H. Bel, Clinical Therapeutics	2019	161
Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitis Jonathan Steinfeld, Eric Bradford, Judith C. Brown, Journal of Allergy and Clinical Immunology	2018	145
The value of blood cytokines and chemokines in assessing COPD Eric Bradford, Sean Jacobson, Jason Varasteh, Respiratory Research	2017	116
Biologic treatment eligibility for real-world patients with severe asthma: The IDEAL study Frank C. Albers, Hana Müllerová, Necdet B. Gunsoy, Journal of Asthma	2017	106
Stopping<i>versus</i>continuing long-term mepolizumab treatment in severe eosinophilic asthma (COMET study) Wendy C. Moore, Oliver Kornmann, Marc Humbert, European Respiratory Journal	2021	103
Long-term safety and pharmacodynamics of mepolizumab in children with severe asthma with an eosinophilic phenotype Atul Gupta, Masanori Ikeda, Bob Geng, Journal of Allergy and Clinical Immunology	2019	99

Page 1